Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Chordoma × Radiotherapy × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 177 Breast Neoplasms 153 Prostatic Neoplasms 142 Lung Neoplasms 137 Glioblastoma 118 Head and Neck Neoplasms 115 Squamous Cell Carcinoma of Head and Neck 109 Rectal Neoplasms 105 Lymphoma 101 Esophageal Neoplasms 100 Pancreatic Neoplasms 76 Leukemia 70 Esophageal Squamous Cell Carcinoma 70 Neoplasms 66 Brain Neoplasms 66 Lymphoma, Follicular 63 Precursor Cell Lymphoblastic Leukemia-Lymphoma 62 Lymphoma, Non-Hodgkin 61 Lymphoma, Large B-Cell, Diffuse 57 Hodgkin Disease 56 Uterine Cervical Neoplasms 53 Central Nervous System Neoplasms 53 Leukemia, Lymphocytic, Chronic, B-Cell 52 Sarcoma 50 Gliosarcoma 50 Colorectal Neoplasms 50 Neoplasm Metastasis 45 Lymphoma, Large-Cell, Immunoblastic 45 Glioma 43 Burkitt Lymphoma 43

Interventions

Nivolumab 5 palbociclib 2 Radiosurgery 2 Protons 2 Proton Therapy 2 Pemetrexed 2 Ipilimumab 2 Imatinib Mesylate 2 tazemetostat 1 relatlimab 1 pembrolizumab 1 nilotinib 1 camrelizumab 1 apatinib 1 Zoledronic Acid 1 Thiotepa 1 Surveys and Questionnaires 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Photochemotherapy 1 Peripheral Blood Stem Cell Transplantation 1 Panobinostat 1 Melphalan 1 Mastectomy, Segmental 1 Immunoglobulin G 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Disulfides 1 Dihematoporphyrin Ether 1 Dasatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01407198 2025-12-19

Nilotinib With Radiation for High Risk Chordoma

Massachusetts General Hospital

Phase 1 Completed

Chordoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡